Curcumin — turmeric root's main active compound — has the joint aisle's most consistent small-trial record: at 500–1,500 mg per day of extract for 8–12 weeks, knee osteoarthritis trials repeatedly show pain relief better than placebo and, in a few head-to-heads, comparable to NSAIDs with fewer stomach complaints. The catches: trials are small and short, plain curcumin is barely absorbed (hence piperine, phospholipid and nano formulas — each trialled little and differently), and case reports of liver injury, particularly with enhanced-absorption products, have accumulated enough for regulator warnings. Blood-thinner users and gallstone owners sit this one out.
What it is
Turmeric is the rhizome that colors curry; curcumin and its sibling curcuminoids are its polyphenol actives, comprising a few percent of the spice. In the lab curcumin inhibits inflammatory machinery broadly (NF-κB signaling, COX-2 among targets) — a résumé so promiscuous it fueled two decades of hype and a famous chemistry-literature warning that curcumin is a "PAINS" compound (interferes with lab assays, flattering itself in test tubes). Human trials, not test tubes, decide this page.
The other defining fact: plain curcumin barely survives digestion — absorption is minimal and clearance fast — which spawned the enhanced-formula industry (piperine/BioPerine co-dosing, phospholipid complexes like Meriva, nano and micellar formats) and complicates every dose comparison between trials.
Evidence by use
Knee osteoarthritis — the flagship. A dozen-plus randomized trials of various extracts, mostly 500–1,500 mg/day curcuminoids for 8–12 weeks: pain and function improve versus placebo with unusual consistency for this aisle, and a few comparisons against ibuprofen/diclofenac found similar relief with fewer GI complaints. Meta-analyses agree, while flagging what keeps the rating at "limited": small samples, short durations, heterogeneous formulas, publication-bias fingerprints, and regional clustering. It is the joint scorecard's best entry — a relative honor.
Inflammatory markers (CRP and friends) fall modestly in pooled small trials — mechanistically consonant, clinically indirect.
Everything else — indigestion and IBS, depression adjunct, metabolic and skin conditions, and the internet's cancer folklore — sits at pilot scale or below; the last category dangerously so wherever it flirts with replacing treatment.
Doses studied
Knee-OA trials cluster at 500–1,000 mg curcuminoids twice daily (plain extracts) or the formula-specific equivalents (e.g., Meriva 1,000 mg providing ~200 mg curcumin). With food, always. Judgment window 8–12 weeks with before/after scoring, per the same protocol as glucosamine.
Safety
Commonly: GI upset, occasionally reflux or diarrhea. The list that matters:
- Bleeding — curcumin inhibits platelets: caution/avoid with warfarin, DOACs, aspirin, clopidogrel; stop 2 weeks pre-surgery.
- Gallbladder — it stimulates bile contraction: avoid with gallstones or bile-duct disease.
- Liver — the recent file per the FAQ: rare idiosyncratic injury, enhanced-absorption products over-represented, regulator warnings issued; standard stop-signals apply.
- Iron — chelation can reduce absorption; separate from iron supplements, note if iron-deficient.
- High doses in pregnancy: avoid (uterine-stimulant tradition, no data); diabetes medication — possible additive glucose lowering, monitor.
- Quality — turmeric powders have a documented lead-adulteration history (coloring fraud); extracts from third-party-tested brands only.
Where it appears in supplements
As standalone extracts (the testable form), in every "inflammation support" and joint blend (typically sub-trial doses beside glucosamine and boswellia), in gummies (doses usually decorative), and in golden-milk romance. Label test: curcuminoid milligrams stated and near trial range, formula named, dose per day computable — or it is turmeric-flavored marketing. Product-by-product findings live in joint supplement research.
Bottom line
For knee OA, curcumin is a defensible 12-week experiment for someone whose medication list permits it: studied dose, tested brand, with food, scored honestly, stopped if silent. It is also this site's recurring lesson in miniature — small trials flatter, absorption chemistry sells, and "natural" carries a liver page — all while the treatment with the actual evidence waits in the gym, unpurchased.
Frequently asked questions
Does cooking with turmeric give any of these effects?
The spice is ~2–5% curcumin, so a generous teaspoon delivers tens of milligrams versus trials' hundreds-to-thousand — with poor absorption on top. Curries are cuisine, not therapy; fat and black pepper in the pan nudge absorption without changing the arithmetic. The culinary dose's virtue is that its safety record is millennia long.
Which enhanced formula is "best" — piperine, Meriva, Theracurmin?
Each raises blood levels by a different route (piperine inhibits your metabolism of curcumin; phospholipid and nano formats package it); each has a handful of its own small trials; none has been fairly raced against the others. Note the asymmetry: boosted absorption plausibly boosts everything, including the liver signal — several injury reports involve piperine combinations. Standardized product, stated curcuminoid dose, tested brand outranks the format debate.
How does the liver risk compare with green tea extract's?
Same genre, smaller file so far: idiosyncratic injury in a minority, reported increasingly since enhanced-absorption products spread, prompting Italian and Australian regulator warnings. Practical translation is identical too — with food, stated modest doses, none with existing liver disease, and stop-and-test for jaundice, dark urine or persistent nausea.
Turmeric or glucosamine for my knees?
On trial consistency, curcumin edges it; on trial size and scrutiny, glucosamine's record is bigger and humbler. Neither approaches exercise-and-weight. A reasonable sequence for the determined experimenter: one at a time, 12 weeks each, honest scoring — and the safety lists decide first (warfarin excludes both; gallstones exclude curcumin).
References
- NCCIH. Turmeric (2020). https://www.nccih.nih.gov/health/turmeric
- National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoarthritis (2023). https://www.niams.nih.gov/health-topics/osteoarthritis
This page discusses supplement ingredients or categories. It may mention a commercial product, with disclosure. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.